
The Senate Judiciary Committee held a hearing to examine competition in the prescription drug market, focusing on patent abuses and promoting competition to lower drug prices. Various experts and lawmakers highlighted the need to address pharmaceutical companies' practices of artificially raising prices through patent system abuse. The hearing emphasized the importance of affordable and accessible medications for patients.
Corporate price gouging and shrinkflation are hurting our seniors on fixed incomes, college students struggling to get by and working families across the country. I'm holding a @SenateBanking hearing on how to fight back to lower costs. Tune in: https://t.co/5WXN8WAexT
The FDA plays a vital role in developing new medications, but this is only beneficial if patients can access & afford them. Today in @EnergyCommerce, I urged my colleagues to support my legislation to encourage competition & ensure approvals are not delayed due to patent gaming. https://t.co/3ULmDG11A9
Life is too expensive for working Minnesota families right now – we must do everything we can to make life more affordable. That’s why I’m working to create a federal task force that will crack down on corporate price gouging and lower costs at the grocery store. https://t.co/IVK1ipitjU








